# FDA Inspection 1303248 - Dendreon Pharmaceuticals LLC - March 25, 2026

Source: https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/18d0f24c-cd63-43db-ac7c-9cb2177b0278
Source feed: FDA_Inspections

> FDA Inspection 1303248 for Dendreon Pharmaceuticals LLC on March 25, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303248
- Company Name: Dendreon Pharmaceuticals LLC
- Inspection Date: 2026-03-25
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1214688 - 2023-08-10](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/4fe7a753-79ef-4ea0-be81-129f0bb9e16c)
- [FDA Inspection 1109236 - 2019-11-08](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/54955f40-a4c2-4bc9-981a-fc18dba66ec3)
- [FDA Inspection 1038072 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/c7e1845f-cb5b-449a-9b17-557e9b813d17)
- [FDA Inspection 961300 - 2016-01-22](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/be5c77a3-ea81-4d35-a080-b28478e98252)
- [FDA Inspection 848259 - 2012-11-15](https://www.keypedia.com/records/fda_inspections/dendreon-pharmaceuticals-llc/d1df774c-a627-4c18-89ed-7cb027877c03)

Company: https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b